ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Yifei Wang
Matched on ORCID iD 0009-0006-2299-4036; OpenAlex author ID A5144302738. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2026: 4 papers
Papers 4
- Single-cell landscape reveals PLPP2 upregulation underlying radiotherapy resistance and immune microenvironment remodeling in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2026.103054↗
- Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilita… Co-author DOI 10.1136/gutjnl-2025-335790↗
- KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy. Co-author DOI 10.1136/gutjnl-2025-336277↗
- Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring. Co-author DOI 10.1158/2159-8290.cd-25-1627↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongjie Xie · 3 shared papers, 2026 · strength 0.67
- Paper KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy… DOI 10.1136/gutjnl-2025-336277↗
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Yukuan Feng · 3 shared papers, 2026 · strength 0.67
- Paper KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy… DOI 10.1136/gutjnl-2025-336277↗
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Tianxing Zhou · 3 shared papers, 2026 · strength 0.67
- Paper KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy… DOI 10.1136/gutjnl-2025-336277↗
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Jihui Hao · 3 shared papers, 2026 · strength 0.67
- Paper KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy… DOI 10.1136/gutjnl-2025-336277↗
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Jing Liu · 2 shared papers, 2026 · strength 0.45
- Paper KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy… DOI 10.1136/gutjnl-2025-336277↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Chongbiao Huang · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Xiuchao Wang · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Song Gao · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Tiansuo Zhao · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Shangheng Shi · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Chao Yang · 2 shared papers, 2026 · strength 0.42
- Paper Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic rep… DOI 10.1136/gutjnl-2025-335790↗
- Paper Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Me… DOI 10.1158/2159-8290.cd-25-1627↗
- Yaoyao Zhou · 1 shared paper, 2026 · strength 0.32
- Weishuai Liu · 1 shared paper, 2026 · strength 0.32
- Shengyu Yang · 1 shared paper, 2026 · strength 0.20
- Zhi Ji · 1 shared paper, 2026 · strength 0.20
- Jun Yu · 1 shared paper, 2026 · strength 0.20
- Qingxiao Fang · 1 shared paper, 2026 · strength 0.20
- Rui Liu · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.